Objective The aim of this study was to investigate the factors affecting rational drug use habits and the use of technological devices in patients with chronic diseases. Methods Adults who applied to the internal medicine outpatient clinics of a university hospital between March and December 2019, who used medications for chronic disease were included in the study. Using a questionnaire, data on demographic characteristics, technology use, smoking and alcohol use, knowledge and behaviour on rational drug use were collected. Results Of the patients, 73.3% (n = 220) had smartphones, 28.0% (n = 84) tablets, 8.7% (n = 26) smartwatches, 6.0% (n = 18) were using smart bracelets, 52.3% (n = 157) knew the e‐pulse application of the Ministry of Health, 53.3% (n = 160) forgot on occasions the time to take their medications, 51.7% (n = 155) threw away some drugs because the expiration date has passed, 64.0% (n = 192) had at home never‐used or unfinished medications, 21.3% (n = 64) had medications to be used ‘in case’, 19.0% (n = 57) recommend drugs to others and 34.3% (n = 103) were getting advice from their environment on drug use. Women were 2.35 times more likely to use technology than men (95% CI: 1.19‐4.64). Decreasing age was associated with an increased likelihood of using technology. Those with an income of more than twice the minimum wage compared with those with an income of minimum wage and below had 3.41 times (95% CI: 1.06‐10.94) higher possibility of using technological devices, while compared with the illiterate, those with secondary education or university education had 14.96 times (95% GA: 3.67‐60.93) higher possibility of using technological devices. Conclusion The patients with chronic diseases demonstrate crucial deficiencies regarding rational drug use. The widespread use of technological devices may be an opportunity for preventive and remedial projects to be developed through these devices. Smartphone‐based self‐management tools should be developed and introduced to chronic patients.

Objective: This study evaluated the effects of a mobile application and integrated Synchronized Medication Tracking System (SMTs) on prospective memory and quality of life to enhance self-management in individuals undergoing pharmacotherapy for chronic conditions.Materials and Methods: Fifty participants were enrolled across two pilot stages (Stage 1: n=40, Stage 2: n=10). Stage 1 engaged with the mobile application for 15 days, while Stage 2 tested the integrated SMTs over 24 hours in hospitalized patients. Prospective memory was assessed via Prospective Memory Questionnaire-4 (PMQ-4), health-related quality of life via Short Form-36 (SF-36), and user satisfaction through structured surveys. Baseline and post-intervention outcomes were compared using paired and between-group analyses.Results: Stage 1 showed improvements in prospective memory (PMQ-4: 14.7±2.1 to 12.5±1.9, p≤0.01). Stage 2 showed no statistically significant changes. SF-36 results indicated improvements in role limitations, emotional well-being, and general health in Stage 1 (p≤0.05 for each), and favorable changes in role limitations due to emotional problems and emotional well-being in Stage 2 (p≤0.05 for each). User feedback indicated high acceptability, with 95% of mobile application users and 90% of integrated system users reporting effective reminders and 80% overall satisfaction in both groups.Conclusion: The mobile application was associated with short-term improvements in prospective memory and psychosocial quality of life. The integrated system demonstrated technical feasibility and high user satisfaction in a hospital setting. The mobile application stage was associated with observable short-term changes in patient-reported outcomes under real-world conditions. Mobile digital systems may support medication-taking by improving cognitive and behavioral determinants.